Ceryvyn Therapeutics Limited - Current Ratio

The Current Ratio as of July 2026 (TTM) for Ceryvyn Therapeutics Limited (CKDXF) is 19.52

According to Ceryvyn Therapeutics Limited’s latest financial reports and current stock price. The company's current Current Ratio is 19.52. This represents a change of 221.98% compared to the average of 6.06 of the last 4 quarters.

Ceryvyn Therapeutics Limited (CKDXF) Historical Current Ratio (quarterly & annually)

How has CKDXF Current Ratio performed in the past?

The mean historical Current Ratio of Ceryvyn Therapeutics Limited over the last ten years is 11.65. The current 19.52 Current Ratio has changed 16.65% with respect to the historical average. Over the past ten years (40 quarters), CKDXF's Current Ratio was at its highest in in the June 2021 quarter at 44.46. The Current Ratio was at its lowest in in the January 2007 quarter at 0.

Ceryvyn Therapeutics Limited (CKDXF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Ceryvyn Therapeutics Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Ceryvyn Therapeutics Limited (CKDXF) Average Current Ratio

How has CKDXF Current Ratio performed in the past?

The current Current Ratio of Ceryvyn Therapeutics Limited (CKDXF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Ceryvyn Therapeutics Limited (CKDXF) Current Ratio vs. Peers

How is CKDXF’s Current Ratio compared to its peers?

Ceryvyn Therapeutics Limited’s Current Ratio is greater than Claritas Pharmaceuticals, Inc. (0.14), greater than Inventiva S.A. (3.16), greater than Oxurion N.V. (0.11), greater than Columbia Care Inc. (1.17), greater than TerrAscend Corp. (1.51), greater than Kindstar Globalgene Technology, Inc. (2.81), greater than SS Innovations International, Inc. (2.54), greater than Adcock Ingram Holdings Limited (2.06), greater than AnGes, Inc. (1.97), greater than Dong Fang Hui Le Inc. (0.11),

Build a custom stock screener for Ceryvyn Therapeutics Limited (CKDXF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ceryvyn Therapeutics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ceryvyn Therapeutics Limited (CKDXF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ceryvyn Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.